CCS ASSOCIATES, INC.

CCS Associates, Inc. specializes in regulatory affairs, medical writing, and technical consulting services for complex biomedical and clinical research programs. The firm provides end-to-end support for regulatory preparation, review, and submission of clinical trial documentation, with deep expertise in FDA alignment, investigational new drug (IND) applications, and oncology drug development pipelines. Their technical capabilities include cancer prevention agent qualification, vendor audit coordination, and information management systems for translational research, serving as a trusted advisor to federal science agencies navigating stringent compliance frameworks. Differentiators include sustained engagement in NCI-led initiatives, mastery of oncology-specific regulatory pathways, and integrated medical writing for INDs, NDAs, and protocol submissions. The company maintains a long-standing, high-frequency relationship with the Department of Health and Human Services, particularly the National Institutes of Health and the National Cancer Institute. Their work centers on supporting the Division of Cancer Prevention with regulatory strategy, technical oversight of investigational agents, and lifecycle management of preclinical-to-clinical development programs. This recurring engagement reflects a trusted advisory role in mission-critical research operations. CCS Associates operates primarily under NAICS 541690, delivering scientific and technical consulting tailored to biopharmaceutical development, with additional experience in biotechnology R&D and broader professional services supporting regulatory compliance. Their market positioning is firmly anchored in the federal biomedical research ecosystem, where precision in regulatory documentation and scientific communication is paramount. As a Women-Owned Small Business and Woman-Owned Business certified contractor based in San Jose, California, CCS Associates brings a nimble, mission-focused approach to federal science contracting. Their certifications enhance accessibility to set-aside opportunities while reinforcing a commitment to diversity in federal contracting. The firm’s geographic presence in the Bay Area positions it advantageously for collaboration with academic medical centers and NIH-affiliated research networks.